Valuation: Strides Pharma Science Limited

Market Cap 99.08B 1.03B 899M 831M 763M 1.44B 1.47B 9.91B 3.89B 48.38B 3.86B 3.78B 167B P/E 2026
15.5x
P/E 2027 * 15.4x
Enterprise Value 99.08B 1.03B 899M 831M 763M 1.44B 1.47B 9.91B 3.89B 48.38B 3.86B 3.78B 167B EV / Sales 2026
1.78x
EV / Sales 2027 * 1.7x
Free-Float
68.07%
Yield 2026
0.53%
Yield 2027 * 0.29%
1 day+2.45%
1 week-0.71%
Current month-1.65%
1 month-2.89%
3 months+7.46%
6 months+23.68%
Current year+19.39%
1 week 1,007.5
Extreme 1007.5
1,100
1 month 1,007.5
Extreme 1007.5
1,149.8
Current year 768.65
Extreme 768.65
1,231
1 year 768.65
Extreme 768.65
1,231
3 years 412.1
Extreme 412.1
1,675
5 years 263.35
Extreme 263.35
1,675
10 years 263.35
Extreme 263.35
1,675
Manager TitleAgeSince
Chief Executive Officer - 01/06/2024
Director of Finance/CFO 42 01/06/2024
Chief Tech/Sci/R&D Officer - 21/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member 82 18/05/2017
Director/Board Member 64 01/02/2024
Change 5-day change 1-year change 3-year change Capi.($)
+2.45%-0.71%+19.99%+142.09% 1B
-0.90%-0.15%+13.46%+79.34% 48.56B
-0.23%-1.65%+65.14%+112.03% 35.65B
-0.76%-1.44%-4.30%+37.38% 11.98B
-0.88%-0.62%+16.38%+89.65% 11.95B
+1.68%+1.90%+34.67%+129.06% 9.29B
-0.91%-1.08%+18.07%+37.00% 6.95B
+3.37%-0.10%+49.31%-3.75% 6.79B
-2.25%-2.08%+0.40%+218.27% 6.7B
+7.04%+17.50%-14.38%+29.12% 6.81B
Average +0.86%+0.78%+19.87%+87.02% 14.57B
Weighted average by Cap. -0.03%+0.55%+26.27%+86.49%

Financials

2026 2027 *
Net sales 48.28B 501M 438M 405M 372M 703M 716M 4.83B 1.9B 23.58B 1.88B 1.84B 81.4B 58.23B 604M 528M 488M 448M 848M 863M 5.83B 2.29B 28.44B 2.27B 2.22B 98.17B
Net income 5.74B 59.54M 52.04M 48.13M 44.16M 83.59M 85.04M 574M 225M 2.8B 224M 219M 9.67B 6.28B 65.15M 56.94M 52.66M 48.32M 91.46M 93.05M 628M 247M 3.07B 245M 239M 10.58B
Net Debt - -
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,301
Date Price Change Volume
17/07/26 1,074.90 +2.45% 427,122
16/07/26 ₹1,049.20 -0.98% 152,888
15/07/26 ₹1,059.60 -1.07% 67,827
14/07/26 ₹1,071.10 -0.27% 62,944
13/07/26 ₹1,074.00 -0.79% 97,494
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,049.20INR
Average target price
1,338.67INR
Spread / Average Target
+27.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STAR Stock